ESC 365 - The key role of RAASi-based therapy in symptomatic heart failure

Open Access

The key role of RAASi-based therapy in symptomatic heart failure

Session: Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy

Topic: Chronic Heart Failure

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Sponsored by PACE-CME - Supported by an unrestricted educational grant from AstraZeneca

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Shelley Zieroth

University of Manitoba, Winnipeg (Canada)

55 presentations

3 followers

4 more presentations in this session

Introduction and a clinical case of a patient with HFrEF

Speaker: Doctor M. Kosiborod (Kansas City, US)

Clinical choices in tackling the risk of hyperkalaemia

Speaker: Doctor M. Kosiborod (Kansas City, US) Doctor S. Zieroth (Winnipeg, CA) Doctor A. Wong (Bridgend, GB)

A practical model for optimising RAASi-based therapy

Speaker: Doctor A. Wong (Bridgend, GB)

Summary and conclusions

Speaker: Doctor M. Kosiborod (Kansas City, US)

Access the full session

Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy

Speakers: Doctor S. Zieroth, Doctor M. Kosiborod, Doctor M. Kosiborod, Doctor S. Zieroth, Doctor A. Wong...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources